Smith Nephew Operating Income Over Time
| SNN Stock | USD 35.61 0.57 1.58% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Smith Nephew Performance and Smith Nephew Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Smith diversify its offerings? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Smith Nephew data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.359 | Dividend Share 0.381 | Earnings Share 1.11 | Revenue Per Share | Quarterly Revenue Growth 0.047 |
Understanding Smith Nephew SNATS requires distinguishing between market price and book value, where the latter reflects Smith's accounting equity. The concept of intrinsic value - what Smith Nephew's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Smith Nephew's price substantially above or below its fundamental value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Smith Nephew's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Smith Nephew SNATS and related stocks such as Hologic, Zimmer Biomet Holdings, and Fresenius Medical Care Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOLX | 1.7 M | 113.7 M | (906.3 M) | 279.7 M | 455.1 M | 548.6 M | 1.4 B | (237.9 M) | 134.4 M | 1.1 B | 2.5 B | 1.6 B | 668.4 M | 882.6 M | 714.3 M | 821.4 M | 862.5 M |
| ZBH | 211 M | 1 B | 1 B | 1 B | 1 B | 467.3 M | 821.1 M | 799.3 M | 33.8 M | 1.1 B | 83.1 M | 860.3 M | 696.3 M | 1.3 B | 1.3 B | 1.4 B | 861 M |
| FMS | 3 B | 1.6 B | 1.7 B | 1.6 B | 1.9 B | 2.1 B | 2.5 B | 2.4 B | 3 B | 2.3 B | 2.3 B | 1.9 B | 1.5 B | 1.4 B | 1.4 B | 1.6 B | 1.6 B |
| MEDP | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 26 M | 20.6 M | 52.5 M | 64.9 M | 101 M | 127.3 M | 167 M | 198.6 M | 278.7 M | 336.8 M | 446.9 M | 534.9 M | 561.7 M |
| RPRX | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | 794.3 M | 722.9 M | 939.7 M | 1.4 B | 2.6 B | 1.6 B | 1.4 B | 307.1 M | 1.5 B | 1.3 B | 1.6 B | 1.3 B |
| TEM | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (119.8 M) | (193.5 M) | (243.7 M) | (265.4 M) | (196.1 M) | (691.1 M) | (622 M) | (590.9 M) |
| COO | 50.4 M | 283.4 M | 305.9 M | 306.5 M | 236.7 M | 324.1 M | 429.1 M | 403.1 M | 546.7 M | 311.8 M | 505.8 M | 507.6 M | 533.1 M | 705.7 M | 682.9 M | 785.3 M | 824.6 M |
| CNC | (6.6 M) | 203.8 M | 108 M | 277 M | 464 M | 705 M | 1.3 B | 1.2 B | 1.5 B | 1.8 B | 3.1 B | 1.8 B | 1.3 B | 2.9 B | 3.2 B | (7.6 B) | (7.2 B) |
| THC | 376 M | 653 M | 749 M | 663 M | 925 M | 1.1 B | 1.2 B | 1.1 B | 1.6 B | 1.5 B | 2 B | 2.9 B | 2.3 B | 2.5 B | 6 B | 3.5 B | 3.7 B |
| NBIX | 2.9 M | 33.9 M | 1.4 M | (49.7 M) | (64.4 M) | (94.2 M) | (147.4 M) | (131.4 M) | 36.9 M | 72.3 M | 163 M | 102.5 M | 249 M | 250.9 M | 570.5 M | 619.1 M | 650.1 M |
Smith Nephew SNATS and related stocks such as Hologic, Zimmer Biomet Holdings, and Fresenius Medical Care Operating Income description
Operating Income is the amount of profit realized from Smith Nephew SNATS operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Smith Nephew SNATS is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Smith Nephew SNATS | SNN |
| Classification | Obamacare Repeal |
| Business Address | Building 5, Watford, |
| Exchange | New York Stock Exchange |
USD 35.61
Check out Smith Nephew Performance and Smith Nephew Correlation. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Smith Nephew technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.